Schrödinger Key Executives
This section highlights Schrödinger's key executives, including their titles and compensation details.
Find Contacts at Schrödinger
(Showing 0 of )
Schrödinger Earnings
This section highlights Schrödinger's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-26 | $-0.35 | $-0.55 |
| Read Transcript | Q3 | 2024 | 2024-11-12 | $-0.40 | $-0.52 |
| Read Transcript | Q2 | 2024 | 2024-08-01 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-05-01 | $-0.76 | $-0.76 |
| Read Transcript | Q4 | 2023 | 2024-02-28 | $-0.44 | $-0.32 |
| Read Transcript | Q3 | 2023 | 2023-11-01 | $-0.69 | $-0.86 |
| Read Transcript | Q2 | 2023 | 2023-08-02 | $-0.43 | $-0.21 |
| Read Transcript | Q1 | 2023 | 2023-05-04 | $1.36 | $-0.38 |
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
$17.97
Stock Price
$1.31B
Market Cap
891
Employees
New York, NY
Location
Financial Statements
Access annual & quarterly financial statements for Schrödinger, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $207.54M | $216.67M | $180.96M | $137.93M | $108.09M |
| Cost of Revenue | $75.46M | $75.97M | $79.93M | $72.31M | $44.62M |
| Gross Profit | $132.08M | $140.69M | $101.02M | $65.62M | $63.47M |
| Gross Profit Ratio | 63.64% | 64.93% | 55.83% | 47.57% | 58.72% |
| Research and Development Expenses | $201.78M | $181.77M | $126.37M | $90.90M | $64.69M |
| General and Administrative Expenses | $99.68M | $99.15M | $90.83M | $64.01M | $41.90M |
| Selling and Marketing Expenses | $39.92M | $37.23M | $30.64M | $22.15M | $17.80M |
| Selling General and Administrative Expenses | $139.59M | $136.37M | $121.47M | $86.16M | $59.69M |
| Other Expenses | $- | $- | $3.95M | $1.06M | $2.25M |
| Operating Expenses | $341.38M | $318.14M | $247.84M | $177.06M | $124.39M |
| Cost and Expenses | $416.83M | $394.11M | $327.77M | $249.37M | $169.01M |
| Interest Income | $- | $- | $3.95M | $1.06M | $2.25M |
| Interest Expense | $- | $- | $3.00K | $- | $- |
| Depreciation and Amortization | $- | $5.55M | $4.34M | $2.85M | $3.66M |
| EBITDA | $-209.30M | $-171.90M | $-142.47M | $-108.60M | $-57.26M |
| EBITDA Ratio | -100.85% | -79.34% | -78.73% | -78.73% | -52.97% |
| Operating Income | $-209.30M | $-177.45M | $-149.12M | $-111.44M | $-60.92M |
| Operating Income Ratio | -100.85% | -81.90% | -82.41% | -80.80% | -56.35% |
| Total Other Income Expenses Net | $23.59M | $220.37M | $-2.31M | $10.63M | $34.62M |
| Income Before Tax | $-185.71M | $42.92M | $-149.13M | $-100.81M | $-26.29M |
| Income Before Tax Ratio | -89.48% | 19.81% | -82.41% | -73.09% | -24.32% |
| Income Tax Expense | $1.41M | $2.20M | $63.00K | $411.00K | $345.00K |
| Net Income | $-187.12M | $40.72M | $-149.19M | $-101.22M | $-26.64M |
| Net Income Ratio | -90.16% | 18.79% | -82.45% | -73.38% | -24.64% |
| EPS | $-2.57 | $0.57 | $-2.10 | $-1.43 | $-0.44 |
| EPS Diluted | $-2.57 | $0.54 | $-2.10 | $-1.43 | $-0.44 |
| Weighted Average Shares Outstanding | 72.67M | 71.78M | 71.17M | 70.59M | 60.02M |
| Weighted Average Shares Outstanding Diluted | 72.67M | 74.99M | 71.17M | 70.59M | 60.02M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.32M | $35.29M | $47.33M | $36.60M | $74.13M | $42.57M | $35.19M | $64.78M | $56.84M | $36.98M | $38.47M | $48.66M | $46.17M | $29.85M | $29.78M | $32.13M | $33.03M | $25.80M | $23.09M | $26.17M |
| Cost of Revenue | $24.19M | $17.56M | $16.00M | $17.71M | $16.58M | $18.93M | $21.38M | $19.09M | $18.14M | $19.78M | $21.34M | $20.68M | $19.81M | $18.73M | $17.80M | $15.96M | $14.04M | $10.53M | $9.51M | $10.55M |
| Gross Profit | $64.13M | $17.73M | $31.34M | $18.89M | $57.55M | $23.64M | $13.81M | $45.69M | $38.70M | $17.20M | $17.13M | $27.98M | $26.36M | $11.12M | $11.98M | $16.16M | $18.99M | $15.27M | $13.58M | $15.62M |
| Gross Profit Ratio | 72.61% | 50.24% | 66.20% | 51.61% | 77.64% | 55.53% | 39.25% | 70.53% | 68.09% | 46.51% | 44.54% | 57.50% | 57.10% | 37.24% | 40.22% | 50.31% | 57.50% | 59.20% | 58.82% | 59.70% |
| Research and Development Expenses | $49.36M | $50.98M | $50.84M | $50.61M | $51.49M | $46.83M | $42.70M | $40.74M | $34.54M | $32.88M | $31.12M | $27.82M | $25.14M | $23.22M | $21.09M | $21.45M | $17.32M | $17.02M | $16.66M | $13.70M |
| General and Administrative Expenses | $25.78M | $24.82M | $23.54M | $25.54M | $25.73M | $23.89M | $23.22M | $26.31M | $23.32M | $23.32M | $22.06M | $22.13M | $17.76M | $17.01M | $15.85M | $13.39M | $13.58M | $9.73M | $9.65M | $8.94M |
| Selling and Marketing Expenses | $9.70M | $10.35M | $9.69M | $10.17M | $9.95M | $9.11M | $9.02M | $9.14M | $9.38M | $7.16M | $7.43M | $6.67M | $5.97M | $5.56M | $5.38M | $5.24M | $4.67M | $3.97M | $4.36M | $4.79M |
| Selling General and Administrative Expenses | $35.48M | $35.17M | $33.23M | $35.71M | $35.68M | $33.00M | $32.24M | $35.45M | $32.70M | $30.48M | $29.48M | $28.80M | $23.73M | $22.57M | $21.23M | $18.63M | $18.26M | $13.70M | $14.01M | $13.72M |
| Other Expenses | $- | $- | $- | $5.03M | $6.63M | $5.80M | $4.33M | $2.94M | $2.69M | $1.23M | $-296.00K | $339.00K | $- | $286.00K | $357.00K | $- | $- | $- | $- | $- |
| Operating Expenses | $84.84M | $86.15M | $84.06M | $86.32M | $87.17M | $79.83M | $74.94M | $76.19M | $67.24M | $63.36M | $60.61M | $56.63M | $48.88M | $45.79M | $42.32M | $40.08M | $35.58M | $30.72M | $30.67M | $27.43M |
| Cost and Expenses | $109.03M | $103.71M | $100.06M | $104.03M | $103.75M | $98.76M | $96.32M | $95.28M | $85.38M | $83.14M | $81.94M | $77.31M | $68.69M | $64.52M | $60.13M | $56.04M | $49.62M | $41.24M | $40.18M | $37.97M |
| Interest Income | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $328.00K | $- | $286.00K | $357.00K | $420.00K | $521.00K | $463.00K | $570.00K | $699.00K |
| Interest Expense | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $19.88M | $328.00K | $6.00K | $286.00K | $357.00K | $420.00K | $521.00K | $463.00K | $570.00K | $699.00K |
| Depreciation and Amortization | $1.76M | $1.56M | $1.40M | $1.44M | $1.35M | $1.27M | $1.17M | $1.76M | $1.14M | $1.11M | $1.13M | $969.00K | $652.00K | $581.00K | $727.00K | $887.00K | $1.01M | $890.00K | $881.00K | $877.00K |
| EBITDA | $-18.95M | $-66.86M | $-51.33M | $-66.00M | $-28.27M | $-54.92M | $-59.97M | $-28.74M | $-27.40M | $-45.06M | $-42.35M | $-27.67M | $-21.86M | $-34.09M | $-29.61M | $-23.02M | $-15.57M | $-14.55M | $-16.21M | $-10.92M |
| EBITDA Ratio | -21.45% | -189.47% | -108.44% | -180.33% | -38.13% | -129.01% | -170.42% | -44.37% | -48.20% | -121.84% | -110.08% | -56.87% | -47.35% | -114.21% | -99.43% | -71.67% | -47.15% | -56.42% | -70.18% | -41.73% |
| Operating Income | $-20.71M | $-68.42M | $-52.73M | $-67.43M | $-29.62M | $-56.19M | $-61.13M | $-30.50M | $-28.54M | $-46.16M | $-43.47M | $-28.64M | $-22.52M | $-34.67M | $-30.34M | $-23.91M | $-16.58M | $-15.45M | $-17.09M | $-11.80M |
| Operating Income Ratio | -23.45% | -193.88% | -111.40% | -184.25% | -39.96% | -132.00% | -173.73% | -47.08% | -50.20% | -124.83% | -113.01% | -58.86% | -48.77% | -116.16% | -101.87% | -74.43% | -50.21% | -59.87% | -74.00% | -45.08% |
| Total Other Income Expenses Net | $-18.54M | $30.20M | $-1.24M | $13.16M | $-1.89M | $-8.72M | $44.98M | $186.00M | $1.19M | $6.50M | $-4.17M | $-5.84M | $-7.93M | $-341.00K | $-4.56M | $23.46M | $5.22M | $18.70M | $13.09M | $-2.38M |
| Income Before Tax | $-39.25M | $-38.23M | $-53.96M | $-54.27M | $-31.51M | $-64.91M | $-16.15M | $155.50M | $-27.34M | $-39.66M | $-47.64M | $-34.48M | $-30.44M | $-35.02M | $-34.90M | $-449.00K | $-11.36M | $3.25M | $-4.00M | $-14.18M |
| Income Before Tax Ratio | -44.45% | -108.32% | -114.01% | -148.28% | -42.51% | -152.48% | -45.90% | 240.03% | -48.10% | -107.25% | -123.84% | -70.85% | -65.93% | -117.30% | -117.19% | -1.40% | -34.39% | 12.60% | -17.33% | -54.18% |
| Income Tax Expense | $963.00K | $-90.00K | $83.00K | $456.00K | $-842.00K | $-2.89M | $-20.43M | $26.36M | $-136.00K | $194.00K | $33.00K | $-28.00K | $274.00K | $-4.00K | $67.00K | $74.00K | $225.00K | $-35.00K | $64.00K | $91.00K |
| Net Income | $-40.22M | $-38.14M | $-54.05M | $-54.72M | $-30.67M | $-62.02M | $4.28M | $129.14M | $-27.21M | $-39.86M | $-47.67M | $-34.45M | $-30.71M | $-35.01M | $-34.64M | $-29.00K | $-11.14M | $3.85M | $-3.35M | $-13.83M |
| Net Income Ratio | -45.54% | -108.06% | -114.18% | -149.53% | -41.38% | -145.70% | 12.16% | 199.34% | -47.87% | -107.78% | -123.93% | -70.80% | -66.52% | -117.28% | -116.32% | -0.09% | -33.72% | 14.93% | -14.51% | -52.82% |
| EPS | $-0.55 | $-0.52 | $-0.74 | $-0.76 | $-0.43 | $-0.86 | $0.06 | $1.81 | $-0.38 | $-0.56 | $-0.67 | $-0.48 | $-0.43 | $-0.49 | $-0.49 | $0.00 | $-0.17 | $0.06 | $-0.05 | $-0.34 |
| EPS Diluted | $-0.55 | $-0.52 | $-0.74 | $-0.76 | $-0.43 | $-0.86 | $0.06 | $1.75 | $-0.38 | $-0.56 | $-0.67 | $-0.48 | $-0.43 | $-0.49 | $-0.49 | $0.00 | $-0.17 | $0.05 | $-0.05 | $-0.34 |
| Weighted Average Shares Outstanding | 72.67M | 72.81M | 72.71M | 72.29M | 72.14M | 71.92M | 71.64M | 71.47M | 71.32M | 71.17M | 71.16M | 71.05M | 70.78M | 70.78M | 70.58M | 70.07M | 66.34M | 66.34M | 63.30M | 40.67M |
| Weighted Average Shares Outstanding Diluted | 72.67M | 72.81M | 72.71M | 72.29M | 72.14M | 71.92M | 75.06M | 73.82M | 71.32M | 71.21M | 71.16M | 71.05M | 70.78M | 70.78M | 70.58M | 70.07M | 66.34M | 72.69M | 63.30M | 40.67M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $147.33M | $155.31M | $90.47M | $120.27M | $202.30M |
| Short Term Investments | $204.80M | $307.69M | $360.61M | $456.21M | $440.39M |
| Cash and Short Term Investments | $352.12M | $463.00M | $451.09M | $576.48M | $642.69M |
| Net Receivables | $255.33M | $89.12M | $69.09M | $40.55M | $35.38M |
| Inventory | $- | $- | $-13.14M | $-8.81M | $-3.96M |
| Other Current Assets | $27.54M | $15.68M | $13.81M | $8.03M | $4.91M |
| Total Current Assets | $634.99M | $567.80M | $533.99M | $625.06M | $682.98M |
| Property Plant Equipment Net | $136.08M | $141.10M | $120.23M | $85.41M | $15.27M |
| Goodwill | $4.79M | $4.79M | $4.79M | $- | $- |
| Intangible Assets | $- | $- | $587.00K | $- | $- |
| Goodwill and Intangible Assets | $4.79M | $4.79M | $5.38M | $- | $- |
| Long Term Investments | $43.21M | $83.25M | $25.68M | $43.17M | $45.66M |
| Tax Assets | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $4.16M | $6.01M | $3.31M | $2.85M | $2.35M |
| Total Non-Current Assets | $188.23M | $235.16M | $154.60M | $131.43M | $63.28M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $823.23M | $802.96M | $688.59M | $756.49M | $746.26M |
| Account Payables | $10.67M | $16.82M | $9.47M | $8.08M | $8.40M |
| Short Term Debt | $16.75M | $16.87M | $22.01M | $2.04M | $9.09M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $111.94M | $56.23M | $57.93M | $55.37M | $45.40M |
| Other Current Liabilities | $52.38M | $43.76M | $13.89M | $25.72M | $8.64M |
| Total Current Liabilities | $191.75M | $133.67M | $108.80M | $91.21M | $73.20M |
| Long Term Debt | $101.07M | $111.01M | $105.48M | $77.83M | $7.22M |
| Deferred Revenue Non-Current | $- | $9.04M | $25.60M | $30.06M | $41.16M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $108.96M | $667.00K | $800.00K | $300.00K | $654.00K |
| Total Non-Current Liabilities | $210.03M | $120.72M | $131.88M | $108.19M | $49.04M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $401.78M | $254.40M | $240.68M | $199.40M | $122.24M |
| Preferred Stock | $- | $- | $- | $- | $746.26M |
| Common Stock | $637.00K | $722.00K | $714.00K | $710.00K | $699.00K |
| Retained Earnings | $-525.54M | $-338.42M | $-379.14M | $-229.95M | $-129.56M |
| Accumulated Other Comprehensive Income Loss | $220.00K | $281.00K | $-2.38M | $-651.00K | $317.00K |
| Other Total Stockholders Equity | $946.13M | $885.97M | $828.70M | $786.96M | $752.56M |
| Total Stockholders Equity | $421.44M | $548.56M | $447.89M | $557.07M | $624.01M |
| Total Equity | $421.44M | $548.56M | $447.90M | $557.09M | $624.02M |
| Total Liabilities and Stockholders Equity | $823.23M | $802.96M | $688.59M | $756.49M | $746.26M |
| Minority Interest | $- | $- | $11.00K | $14.00K | $4.00K |
| Total Liabilities and Total Equity | $823.23M | $802.96M | $688.59M | $756.49M | $746.26M |
| Total Investments | $248.01M | $390.94M | $386.30M | $499.38M | $486.06M |
| Total Debt | $117.83M | $127.88M | $116.49M | $79.87M | $11.76M |
| Net Debt | $-29.50M | $-27.43M | $26.02M | $-40.40M | $-190.53M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $147.33M | $160.42M | $108.11M | $130.24M | $161.07M | $249.38M | $285.96M | $233.21M | $90.47M | $102.82M | $127.32M | $117.26M | $120.27M | $160.88M | $117.70M | $133.12M | $202.30M | $210.49M | $110.38M | $144.75M |
| Short Term Investments | $204.80M | $228.26M | $269.18M | $300.84M | $307.69M | $246.91M | $262.71M | $294.48M | $360.61M | $370.74M | $382.25M | $408.27M | $456.21M | $436.31M | $495.89M | $515.37M | $440.39M | $388.49M | $173.65M | $143.50M |
| Cash and Short Term Investments | $352.12M | $388.68M | $377.29M | $431.08M | $468.75M | $496.28M | $548.67M | $527.69M | $451.09M | $473.56M | $509.56M | $525.53M | $576.48M | $597.19M | $613.59M | $648.49M | $642.69M | $598.98M | $284.03M | $288.25M |
| Net Receivables | $255.33M | $44.82M | $52.17M | $45.62M | $89.12M | $32.14M | $24.24M | $60.16M | $69.09M | $35.74M | $31.75M | $45.59M | $40.55M | $16.33M | $25.90M | $18.29M | $35.38M | $17.18M | $17.19M | $18.18M |
| Inventory | $- | $- | $- | $1 | $- | $-12.25M | $-14.59M | $-13.47M | $-13.14M | $- | $1 | $- | $1 | $2 | $- | $- | $1 | $2 | $- | $- |
| Other Current Assets | $27.54M | $22.90M | $19.72M | $16.99M | $9.93M | $19.34M | $19.05M | $15.88M | $13.81M | $14.91M | $15.56M | $15.04M | $8.03M | $8.51M | $10.29M | $8.45M | $4.91M | $4.95M | $5.79M | $6.38M |
| Total Current Assets | $634.99M | $456.40M | $449.18M | $493.69M | $567.80M | $547.76M | $591.96M | $603.73M | $533.99M | $524.20M | $556.87M | $586.17M | $625.06M | $622.02M | $649.79M | $675.24M | $682.98M | $621.11M | $307.01M | $312.81M |
| Property Plant Equipment Net | $136.08M | $137.74M | $142.25M | $144.71M | $141.10M | $142.32M | $133.34M | $122.47M | $120.23M | $102.22M | $101.66M | $89.26M | $85.41M | $85.53M | $14.45M | $13.66M | $15.27M | $15.88M | $17.75M | $19.73M |
| Goodwill | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $587.00K | $720.00K | $853.00K | $986.00K | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | $5.38M | $5.51M | $5.64M | $5.78M | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $43.21M | $65.22M | $88.56M | $91.39M | $83.25M | $91.86M | $106.40M | $101.54M | $25.68M | $27.18M | $21.90M | $37.00M | $43.17M | $51.09M | $49.71M | $52.93M | $45.66M | $40.91M | $22.68M | $15.16M |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $4.16M | $5.15M | $3.60M | $3.19M | $6.01M | $7.41M | $5.07M | $6.23M | $3.31M | $2.88M | $1.80M | $1.33M | $2.85M | $3.97M | $3.38M | $2.36M | $2.35M | $2.21M | $2.10M | $2.17M |
| Total Non-Current Assets | $188.23M | $212.90M | $239.19M | $244.08M | $235.16M | $246.39M | $249.60M | $235.04M | $154.60M | $137.78M | $131.01M | $133.37M | $131.43M | $140.59M | $67.55M | $68.95M | $63.28M | $59.00M | $42.54M | $37.06M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $823.23M | $669.30M | $688.37M | $737.76M | $802.96M | $794.15M | $841.57M | $838.77M | $688.59M | $661.99M | $687.88M | $719.54M | $756.49M | $762.62M | $717.33M | $744.19M | $746.26M | $680.12M | $349.55M | $349.87M |
| Account Payables | $10.67M | $11.21M | $8.12M | $9.97M | $16.82M | $10.32M | $12.43M | $11.99M | $9.47M | $10.92M | $5.26M | $9.77M | $8.08M | $8.23M | $5.96M | $7.22M | $8.40M | $4.81M | $5.52M | $6.67M |
| Short Term Debt | $16.75M | $- | $33.60M | $33.85M | $16.87M | $32.56M | $27.84M | $23.62M | $22.01M | $17.37M | $14.36M | $8.30M | $2.04M | $3.96M | $5.04M | $7.15M | $9.09M | $10.98M | $11.68M | $11.70M |
| Tax Payables | $- | $- | $- | $- | $- | $1.08M | $5.13M | $26.32M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $111.94M | $41.77M | $40.80M | $49.50M | $56.23M | $43.31M | $46.67M | $51.58M | $57.93M | $43.92M | $47.44M | $53.77M | $55.37M | $43.87M | $44.07M | $40.76M | $45.40M | $19.07M | $23.14M | $21.71M |
| Other Current Liabilities | $52.38M | $58.13M | $10.16M | $6.82M | $43.76M | $10.02M | $13.25M | $9.90M | $13.89M | $14.33M | $20.52M | $16.43M | $25.72M | $19.71M | $20.08M | $14.63M | $8.64M | $1.13M | $-339.00K | $-587.00K |
| Total Current Liabilities | $191.75M | $111.12M | $99.76M | $106.51M | $133.67M | $105.04M | $106.80M | $123.41M | $108.80M | $88.82M | $85.59M | $85.53M | $91.21M | $72.92M | $70.38M | $67.62M | $73.20M | $39.28M | $43.05M | $42.17M |
| Long Term Debt | $101.07M | $103.26M | $107.13M | $108.99M | $111.01M | $112.72M | $107.32M | $104.06M | $105.48M | $87.17M | $88.11M | $77.35M | $77.83M | $77.14M | $6.43M | $6.84M | $7.22M | $6.76M | $7.78M | $9.13M |
| Deferred Revenue Non-Current | $- | $- | $7.08M | $8.02M | $9.04M | $12.10M | $15.62M | $20.35M | $25.60M | $21.98M | $20.11M | $24.58M | $30.06M | $32.44M | $34.46M | $37.36M | $41.16M | $2.59M | $1.98M | $2.12M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $-8.02M | $-1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $108.96M | $5.50M | $424.00K | $545.00K | $667.00K | $707.00K | $600.00K | $700.00K | $800.00K | $900.00K | $1.00M | $1.40M | $300.00K | $300.00K | $300.00K | $600.00K | $654.00K | $600.00K | $600.00K | $900.00K |
| Total Non-Current Liabilities | $210.03M | $108.75M | $114.63M | $117.55M | $120.72M | $125.53M | $123.54M | $125.11M | $131.88M | $110.04M | $109.22M | $103.33M | $108.19M | $109.88M | $41.19M | $44.79M | $49.04M | $9.95M | $10.36M | $12.16M |
| Other Liabilities | $- | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $401.78M | $219.87M | $214.39M | $224.06M | $254.40M | $230.57M | $230.34M | $248.51M | $240.68M | $198.86M | $194.81M | $188.87M | $199.40M | $182.79M | $111.56M | $112.41M | $122.24M | $49.23M | $53.40M | $54.32M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $680.12M | $349.55M | $349.87M |
| Common Stock | $637.00K | $637.00K | $728.00K | $727.00K | $722.00K | $720.00K | $719.00K | $715.00K | $714.00K | $712.00K | $712.00K | $712.00K | $710.00K | $709.00K | $708.00K | $705.00K | $699.00K | $695.00K | $633.00K | $633.00K |
| Retained Earnings | $-525.54M | $-485.32M | $-447.19M | $-393.14M | $-338.42M | $-307.75M | $-245.72M | $-250.00M | $-379.14M | $-351.93M | $-312.08M | $-264.39M | $-229.95M | $-199.24M | $-164.23M | $-129.59M | $-129.56M | $-118.42M | $-122.27M | $-118.92M |
| Accumulated Other Comprehensive Income Loss | $220.00K | $597.00K | $-180.00K | $-72.00K | $281.00K | $-491.00K | $-683.00K | $-899.00K | $-2.38M | $-3.69M | $-3.40M | $-2.66M | $-651.00K | $44.00K | $76.00K | $77.00K | $317.00K | $480.00K | $727.00K | $-442.00K |
| Other Total Stockholders Equity | $946.13M | $933.52M | $920.62M | $906.19M | $885.97M | $871.10M | $856.91M | $840.45M | $828.70M | $818.01M | $807.83M | $797.00M | $786.96M | $778.29M | $769.20M | $760.57M | $752.56M | $748.12M | $417.03M | $414.25M |
| Total Stockholders Equity | $421.44M | $449.43M | $473.98M | $513.71M | $548.56M | $563.58M | $611.23M | $590.26M | $447.89M | $463.11M | $493.06M | $530.67M | $557.07M | $579.81M | $605.75M | $631.77M | $624.01M | $630.88M | $296.12M | $295.52M |
| Total Equity | $421.44M | $449.43M | $473.98M | $513.71M | $548.56M | $563.58M | $611.23M | $590.26M | $447.90M | $463.12M | $493.07M | $530.67M | $557.09M | $579.82M | $605.77M | $631.78M | $624.02M | $630.89M | $296.15M | $295.55M |
| Total Liabilities and Stockholders Equity | $823.23M | $669.30M | $688.37M | $737.76M | $802.96M | $794.15M | $841.57M | $838.77M | $688.59M | $661.99M | $687.88M | $719.54M | $756.49M | $762.62M | $717.33M | $744.19M | $746.26M | $680.12M | $349.55M | $349.87M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $11.00K | $12.00K | $15.00K | $3.00K | $14.00K | $16.00K | $20.00K | $8.00K | $4.00K | $8.00K | $27.00K | $31.00K |
| Total Liabilities and Total Equity | $823.23M | $669.30M | $688.37M | $737.76M | $802.96M | $794.15M | $841.57M | $838.77M | $688.59M | $661.99M | $687.88M | $719.54M | $756.49M | $762.62M | $717.33M | $744.19M | $746.26M | $680.12M | $349.55M | $349.87M |
| Total Investments | $248.01M | $293.48M | $357.74M | $392.23M | $390.94M | $338.77M | $369.11M | $396.02M | $386.30M | $397.92M | $404.15M | $445.28M | $499.38M | $487.39M | $545.61M | $568.30M | $486.06M | $429.41M | $196.33M | $158.66M |
| Total Debt | $117.83M | $120.14M | $123.93M | $125.92M | $127.88M | $129.00M | $121.24M | $115.87M | $116.49M | $95.85M | $95.29M | $81.50M | $79.87M | $79.11M | $8.95M | $10.41M | $11.76M | $12.25M | $13.62M | $14.98M |
| Net Debt | $-29.50M | $-40.27M | $15.82M | $-4.32M | $-33.18M | $-120.38M | $-164.72M | $-117.34M | $26.02M | $-6.97M | $-32.03M | $-35.75M | $-40.40M | $-81.77M | $-108.75M | $-122.71M | $-190.53M | $-198.24M | $-96.76M | $-129.76M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $-187.12M | $40.72M | $-149.19M | $-101.22M | $-26.64M |
| Depreciation and Amortization | $6.16M | $5.55M | $4.34M | $2.85M | $3.66M |
| Deferred Income Tax | $- | $- | $- | $-4.28M | $-32.12M |
| Stock Based Compensation | $49.90M | $47.84M | $39.63M | $26.49M | $10.54M |
| Change in Working Capital | $-13.04M | $-22.55M | $-21.38M | $4.68M | $59.18M |
| Accounts Receivables | $-169.70M | $-20.03M | $-23.70M | $-321.00K | $-12.75M |
| Inventory | $- | $- | $- | $6.44M | $7.34M |
| Accounts Payables | $-6.12M | $7.32M | $1.18M | $-411.00K | $4.88M |
| Other Working Capital | $162.78M | $-9.85M | $1.14M | $-1.03M | $59.70M |
| Other Non Cash Items | $-13.27M | $-208.29M | $6.91M | $811.00K | $2.14M |
| Net Cash Provided by Operating Activities | $-157.37M | $-136.73M | $-119.68M | $-70.67M | $16.76M |
| Investments in Property Plant and Equipment | $-7.31M | $-13.40M | $-8.01M | $-7.17M | $-2.54M |
| Acquisitions Net | $- | $- | $-7.03M | $12.04M | $-2.87M |
| Purchases of Investments | $-254.41M | $-324.75M | $-271.47M | $-414.80M | $-519.67M |
| Sales Maturities of Investments | $410.56M | $383.97M | $364.71M | $392.75M | $138.77M |
| Other Investing Activities | $- | $147.21M | $11.82M | $375.00K | $4.58M |
| Net Cash Used for Investing Activities | $148.84M | $193.03M | $90.02M | $-16.81M | $-381.72M |
| Debt Repayment | $-58.00K | $-19.00K | $- | $- | $- |
| Common Stock Issued | $8.87M | $9.07M | $2.11M | $7.93M | $537.09M |
| Common Stock Repurchased | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $1.31M | $9.07M | $2.11M | $7.95M | $4.18M |
| Net Cash Used Provided by Financing Activities | $10.12M | $9.05M | $2.11M | $7.95M | $541.27M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- |
| Net Change in Cash | $1.59M | $65.35M | $-27.55M | $-79.53M | $176.31M |
| Cash at End of Period | $162.66M | $161.07M | $95.72M | $123.27M | $202.80M |
| Cash at Beginning of Period | $161.07M | $95.72M | $123.27M | $202.80M | $26.49M |
| Operating Cash Flow | $-157.37M | $-136.73M | $-119.68M | $-70.67M | $16.76M |
| Capital Expenditure | $-7.31M | $-13.40M | $-8.01M | $-7.17M | $-2.54M |
| Free Cash Flow | $-164.68M | $-150.14M | $-127.70M | $-77.84M | $14.22M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-40.22M | $-38.14M | $-54.05M | $-54.72M | $-30.67M | $-62.02M | $4.28M | $129.14M | $-27.21M | $-39.86M | $-47.67M | $-34.45M | $-30.71M | $-35.01M | $-34.97M | $-523.00K | $-11.59M | $3.29M | $-4.07M | $-14.27M |
| Depreciation and Amortization | $1.76M | $1.56M | $1.40M | $1.44M | $1.35M | $1.27M | $1.17M | $1.76M | $1.14M | $1.11M | $1.13M | $969.00K | $652.00K | $581.00K | $727.00K | $887.00K | $1.01M | $890.00K | $881.00K | $877.00K |
| Deferred Income Tax | $- | $- | $- | $- | $-65.64M | $-2.89M | $-30.71M | $- | $- | $- | $- | $- | $2.00K | $4.00K | $5.30M | $-21.07M | $-4.47M | $-17.84M | $-12.93M | $3.12M |
| Stock Based Compensation | $12.48M | $12.40M | $12.81M | $12.22M | $12.53M | $12.65M | $11.77M | $10.88M | $10.21M | $9.86M | $10.43M | $9.13M | $7.46M | $7.65M | $7.02M | $4.37M | $3.00M | $3.04M | $2.73M | $1.77M |
| Change in Working Capital | $-25.89M | $17.94M | $-17.70M | $12.61M | $-26.19M | $-14.34M | $6.83M | $11.15M | $-9.11M | $3.39M | $7.38M | $-23.04M | $-5.54M | $13.05M | $-7.76M | $4.92M | $55.22M | $-1.95M | $3.62M | $2.29M |
| Accounts Receivables | $-210.51M | $7.35M | $-6.55M | $46.15M | $-56.98M | $-10.23M | $37.04M | $9.26M | $-32.37M | $-4.82M | $10.55M | $2.94M | $-20.39M | $10.01M | $-10.09M | $20.15M | $-19.13M | $1.56M | $2.42M | $2.40M |
| Inventory | $- | $- | $- | $- | $-729.00K | $2.22M | $-18.30M | $- | $- | $- | $- | $- | $5.88M | $2.94M | $3.17M | $-5.55M | $5.76M | $520.00K | $-98.00K | $1.15M |
| Accounts Payables | $-677.00K | $3.50M | $-1.79M | $-7.15M | $6.58M | $550.00K | $-2.28M | $2.47M | $-1.42M | $5.54M | $-4.27M | $1.33M | $-182.00K | $2.26M | $-1.26M | $-1.23M | $3.63M | $-745.00K | $-111.00K | $2.11M |
| Other Working Capital | $185.30M | $7.09M | $-9.36M | $-7.76M | $24.94M | $-6.88M | $-9.63M | $-577.00K | $24.68M | $2.67M | $1.09M | $-27.30M | $9.16M | $-2.16M | $417.00K | $-8.45M | $64.96M | $-3.29M | $1.41M | $-3.38M |
| Other Non Cash Items | $20.75M | $-27.01M | $3.82M | $-13.51M | $71.44M | $15.38M | $-11.77M | $-184.02M | $25.00K | $-4.87M | $4.08M | $7.66M | $8.40M | $3.09M | $313.00K | $498.00K | $443.00K | $547.00K | $712.00K | $435.00K |
| Net Cash Provided by Operating Activities | $-31.11M | $-33.26M | $-53.72M | $-39.28M | $-37.18M | $-49.94M | $-18.44M | $-31.09M | $-24.94M | $-30.36M | $-24.66M | $-39.72M | $-19.74M | $-10.64M | $-29.37M | $-10.92M | $43.62M | $-12.03M | $-9.05M | $-5.78M |
| Investments in Property Plant and Equipment | $-873.00K | $-1.34M | $-1.00M | $-4.09M | $-2.48M | $-4.92M | $-2.43M | $-3.58M | $-1.35M | $-3.00M | $-1.97M | $-1.70M | $-957.00K | $-2.78M | $-2.91M | $-513.00K | $-886.00K | $-325.00K | $-484.00K | $-843.00K |
| Acquisitions Net | $-72.00K | $3.00M | $-3.00M | $- | $4.12M | $- | $- | $-4.12M | $600.00K | $- | $-600.00K | $-6.43M | $-12.04M | $-2.00M | $-1.70M | $15.73M | $2.87M | $- | $- | $-2.87M |
| Purchases of Investments | $-63.87M | $-33.95M | $-119.39M | $-37.13M | $-96.11M | $-98.80M | $-66.89M | $-58.82M | $-68.10M | $-92.16M | $-56.15M | $-55.07M | $-74.29M | $-117.78M | $-79.05M | $-143.67M | $-72.85M | $-269.12M | $-50.59M | $-127.11M |
| Sales Maturities of Investments | $88.29M | $126.00M | $149.97M | $46.30M | $38.90M | $116.90M | $100.77M | $127.40M | $81.00M | $103.00M | $81.22M | $99.50M | $53.16M | $174.94M | $98.14M | $66.50M | $20.50M | $53.46M | $21.90M | $42.91M |
| Other Investing Activities | $- | $-3.00M | $3.00M | $9.17M | $-4.12M | $19.00K | $35.79M | $111.33M | $-600.00K | $-3.00K | $11.83M | $44.43M | $12.04M | $55.16M | $335.00K | $40.00K | $-2.87M | $-215.66M | $4.58M | $-87.07M |
| Net Cash Used for Investing Activities | $23.48M | $90.70M | $29.58M | $5.08M | $-59.69M | $13.20M | $67.24M | $172.20M | $11.56M | $7.84M | $34.32M | $36.30M | $-22.09M | $52.38M | $14.81M | $-61.91M | $-53.24M | $-215.98M | $-24.59M | $-87.91M |
| Debt Repayment | $-15.00K | $-14.00K | $-15.00K | $-14.00K | $-14.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $177.00K | $-558.00K | $1.06M | $7.63M | $2.34M | $1.33M | $4.52M | $867.00K | $2.11M | $324.00K | $396.00K | $908.00K | $7.93M | $1.44M | $1.61M | $3.66M | $-10.00K | $325.61M | $-731.00K | $212.28M |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-731.00K | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-43.00K | $406.00K | $558.00K | $392.00K | $2.34M | $1.33M | $4.52M | $867.00K | $482.00K | $324.00K | $396.00K | $908.00K | $1.22M | $1.44M | $1.64M | $3.66M | $1.43M | $2.52M | $55.00K | $177.00K |
| Net Cash Used Provided by Financing Activities | $119.00K | $392.00K | $1.61M | $8.01M | $2.33M | $1.33M | $4.52M | $867.00K | $482.00K | $324.00K | $396.00K | $908.00K | $1.22M | $1.44M | $1.64M | $3.66M | $1.43M | $328.12M | $-731.00K | $212.45M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $-29.50M | $-41.55M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-7.52M | $57.84M | $-22.54M | $-26.19M | $-94.54M | $-35.41M | $53.32M | $141.97M | $-12.90M | $-22.20M | $10.06M | $-2.51M | $-40.61M | $43.18M | $-12.92M | $-69.17M | $-8.19M | $100.11M | $-34.37M | $118.76M |
| Cash at End of Period | $162.66M | $170.18M | $112.34M | $134.87M | $161.07M | $255.61M | $291.02M | $237.69M | $95.72M | $108.62M | $130.82M | $120.76M | $123.27M | $163.88M | $120.70M | $133.62M | $202.80M | $210.99M | $110.88M | $145.25M |
| Cash at Beginning of Period | $170.18M | $112.34M | $134.87M | $161.07M | $255.61M | $291.02M | $237.69M | $95.72M | $108.62M | $130.82M | $120.76M | $123.27M | $163.88M | $120.70M | $133.62M | $202.80M | $210.99M | $110.88M | $145.25M | $26.49M |
| Operating Cash Flow | $-31.11M | $-33.26M | $-53.72M | $-39.28M | $-37.18M | $-49.94M | $-18.44M | $-31.09M | $-24.94M | $-30.36M | $-24.66M | $-39.72M | $-19.74M | $-10.64M | $-29.37M | $-10.92M | $43.62M | $-12.03M | $-9.05M | $-5.78M |
| Capital Expenditure | $-873.00K | $-1.34M | $-1.00M | $-4.09M | $-2.48M | $-4.92M | $-2.43M | $-3.58M | $-1.35M | $-3.00M | $-1.97M | $-1.70M | $-957.00K | $-2.78M | $-2.91M | $-513.00K | $-886.00K | $-325.00K | $-484.00K | $-843.00K |
| Free Cash Flow | $-31.99M | $-34.60M | $-54.72M | $-43.37M | $-39.66M | $-54.86M | $-20.87M | $-34.67M | $-26.29M | $-33.36M | $-26.63M | $-41.42M | $-20.70M | $-13.42M | $-32.29M | $-11.43M | $42.73M | $-12.36M | $-9.54M | $-6.62M |
Schrödinger Dividends
Explore Schrödinger's dividend history, including dividend yield, payout ratio, and historical payments.
Schrödinger News
Read the latest news about Schrödinger, including recent articles, headlines, and updates.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company's common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 6,943 shares of the company's common stock to seven newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of.
Schrödinger: Still Waiting On A Catalyst
Schrödinger's Q4 2024 results and 2025 guidance were solid, yet the company's share price remains low due to ongoing losses. Cash burn is likely to moderate going forward, as investments in the company's internal pipeline have now stabilized. Regardless, cash burn concerns are misplaced, as Schrödinger has demonstrated that it can manage its liquidity position through things like partnerships and licensing.
Schrödinger, Inc. (SDGR) Q4 2024 Earnings Call Transcript
Schrödinger, Inc. (NASDAQ:SDGR ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Affairs Ramy Farid - President & Chief Executive Officer Geoff Porges - Chief Financial Officer Karen Akinsanya - President, R&D & Therapeutics Conference Call Participants Kyle Yang - Jefferies CJ Yeh - Leerink Partners Brendan Smith - TD Cowen Michael Ryskin - Bank of America Vikram Purohit - Morgan Stanley Malcolm Hoffman - BMO Capital Markets Matt Hewitt - Craig-Hallum Capital Group Chris Shibutani - Goldman Sachs Operator Thank you for standing by. Welcome to Schrödinger's conference call to review Fourth Quarter and Full Year 2024 Financial Results.
Schrödinger to Participate in Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 45th Annual Health Care Conference: Fireside chat on Tuesday, March 4, 2025 at 10:30 a.m. E.T. Leerink Partners Global Biopharma Conference 2025: Fireside chat on Monday, March 10, 2025 at 3:40 p.m. E.T. KBCM Healthcare Forum: Fireside chat on Tuesday, March 18, 2025 at 9:00 a.m. E.T. The live discussions can be accessed in the “Investors” sectio.
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025. “We are very proud of our accomplishments in 2024. We advanced the capabilities of our computational platform and leveraged the synergies in our business, which included signing a multi-target research collaboration and expanded software licensing agreement with Novartis. We are pleased another innovative pharmaceutical.
Schrodinger price target raised to $28 from $27 at Goldman Sachs
Goldman Sachs raised the firm's price target on Schrodinger (SDGR) to $28 from $27 and keeps a Neutral rating on the shares. The company's Q3 results and announced deal with Novartis (NVS) involving both a research and expanded software utilization collaboration drove the stock higher, and while operating results from the quarter came in slightly below expectations, the management relayed confidence in the forward outlook for the balance of the year for the company's Software business, noting resiliency across large and mid-sized ACV accounts with increasing depth of utilization, the analyst tells investors in a research note. Schrodinger -0.165 (-0.74%) Novartis -1.08 (-1.03%)
Schrödinger (SDGR) Q3 2024 Earnings Call Transcript
Schrödinger Inc. (NASDAQ:SDGR ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Ramy Farid - President, Chief Executive Officer Karen Akinsanya - President, R&D and Therapeutics Geoff Porges - Chief Financial Officer Jaren Madden - Senior Vice President, Corporate Affairs and Investor Relations Conference Call Participants Matt - Jefferies Mani Foroohar - Leerink Partners Steve - Keybanc Gaspa - Morgan Stanley Evan Seigerman - BMO Capital Markets Joe Catanzaro - Piper Sandler Toff - Craig Hallum Brendan Smith - TD Cowen Sean Kim - Bank of America John - Citi Operator Welcome to Schrödinger's conference call to review our third quarter 2024 financial results. My name is Madison and I will be your Operator for today's call.
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, during a poster session at the 36th EORTC-NCI-AACR Symposium (ENA 2024). The data demonstrate that in preclinical models, treatment with SGR-3515 results in synergistic anti-tumor activity that leads to deeper and more durable responses compared to inhibitors that target only Wee1 or Myt1. The preclinical data also show that SGR-3515 has a favorable ph.
Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm
NEW YORK , Sept. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Schrodinger, Inc. (NASDAQ: SDGR) breached their fiduciary duties to shareholders.
2 Bill Gates stocks to turn $100 into $1,000 by 2025
Bill Gates has been named the world's richest man a record 18 times. Although the billionaire has shifted his focus to philanthropic efforts as time has gone on, the Bill & Melinda Gates Foundation Trust still relies on stock investments to finance its worthwhile goals.
The 3 Best Med Tech Stocks to Buy Now
According to the Advanced Medical Technology Association, med tech is defined as “companies that develop, manufacture, and distribute the technologies, devices, equipment, diagnostic tests, and health information systems.” The organization reports that these firms favorably change health care with “earlier disease detection, less-invasive procedures, and more effective treatments.
Schrödinger, Inc. (SDGR) Q2 2024 Earnings Call Transcript
Schrödinger, Inc. (NASDAQ:SDGR ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Communications Ramy Farid - President & Chief Executive Officer Geoff Porges - Chief Financial Officer Karen Akinsanya - President R&D, Therapeutics Conference Call Participants Michael Yee - Jefferies Scott Schoenhaus - KeyBanc Conor McKay - BMO Capital Markets David Leibowitz - Citi Matt Hewitt - Craig-Hallam Capital Chris Shibutani - Goldman Sachs Steven Mah - TD Cowen Operator Thank you for standing by. Welcome to Schrödinger's Conference Call to review our Second Quarter 2024 Financial Results.
Compared to Estimates, Schrodinger (SDGR) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Schrodinger (SDGR) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for SDGR.